VLTO
Next earnings: Jul 23, 2026 · After close
Signal
Leaning Bearish1
Price
1
Move-0.12%Quiet session
Volume
1
Volume0.7× avgNormal activity
Technical
1
RSIRSI 44Momentum negative
PRICE
Prev Close
88.24
Open
88.06
Day Range87.68 – 89.47
87.68
89.47
52W Range84.99 – 110.11
84.99
110.11
13% of range
VOLUME & SIZE
Avg Volume
2.2M
FUNDAMENTALS
P/E Ratio
22.7x
EPS (TTM)
Div Yield
No dividend
Performance
1D
-0.12%
5D
-1.83%
1M
-0.68%
3M
-2.93%
6M
-11.80%
YTD
-11.68%
1Y
-7.90%
Worst: 6M (-11.80%)
Quick Read
TrendInsufficient MA data
Momentum
BULLISH
revenue +6% YoY
Valuation
FAIR
P/E 23x vs ~20x sector
Health
MODERATE
FCF $4.21/sh
Bullish
Key MetricsTTM
Market Cap$21.64B
Revenue TTM$5.59B
Net Income TTM$969.00M
Free Cash Flow$1.04B
Gross Margin
Net Margin
Operating Margin
Return on Equity33.4%
Return on Assets
Debt / Equity0.89
Current Ratio1.48
EPS TTM$3.91
Alpha SignalsFull Analysis →
What Moves This Stock

Water Quality segment organic growth driven by PFAS/PFOA remediation spending and EPA regulatory timelines for municipal water treatment upgrades

Product Quality consumable pull-through rates and equipment placements in food/beverage packaging lines, particularly in emerging markets

Margin expansion trajectory from Danaher Business System implementation and software/digital mix shift

M&A activity in fragmented water testing and serialization software markets where Veralto can deploy $1B+ in acquisition capacity

Macro Sensitivity
Economic Cycle

moderate - Water Quality (~60% of revenue) exhibits defensive characteristics tied to non-discretionary municipal water treatment and regulatory compliance, providing stability during downturns. Product Quality (~40%) has higher cyclical exposure to food/beverage/pharma production volumes and industrial capex spending. Overall revenue correlation to industrial production is approximately 0.4-0.5x, with geographic diversification (40% North America, 35% Europe, 25% high-growth markets) smoothing regional cycles.

Interest Rates

Rising rates create headwinds through two channels: (1) municipal water utilities face higher borrowing costs for infrastructure projects, potentially delaying discretionary upgrades beyond regulatory-mandated spending, and (2) valuation multiple compression as investors rotate from high-quality industrials (trading 17-18x EBITDA) toward higher-yielding alternatives. However, limited direct debt refinancing risk given 0.86x debt/equity and investment-grade balance sheet. Customer financing costs matter more than Veralto's own cost of capital.

Key Risks

Regulatory risk from potential delays or weakening of EPA PFAS standards and drinking water regulations that drive 15-20% of Water Quality demand; political shifts could slow municipal compliance timelines

Technology disruption in water testing from lower-cost sensor technologies and AI-driven predictive monitoring systems that could commoditize traditional lab equipment sales

Consolidation among food/beverage customers (Nestle, PepsiCo, AB InBev) increasing buyer negotiating power and pressuring Product Quality pricing on global supply agreements

Investor Profile

growth - Investors seek exposure to secular water infrastructure and food safety themes with 6-8% organic growth potential, 200-300bps annual margin expansion, and Danaher-pedigree operational execution. The stock attracts quality-focused growth investors willing to pay 17-18x EBITDA for defensive end-market exposure (60% Water Quality) balanced with higher-growth Product Quality. Recent 15% drawdown from highs creates entry point for long-term holders betting on multi-year PFAS remediation cycle and software mix shift driving 12-15% EPS growth.

Watch on Earnings
EPA PFAS regulatory timeline and state-level drinking water standards adoption rates driving municipal treatment equipment demandU.S. municipal water infrastructure spending from State Revolving Funds (SRF) and IIJA grant disbursementsIndustrial production indices in food/beverage and pharmaceutical manufacturing (primary Product Quality end markets)Consumable pull-through rates (inks, reagents, test kits) as percentage of installed equipment base revenue
Health Radar
3 strong
71/100
Leverage
0.89Strong
ROIC
16.3%Strong
Cash
$2.0BStrong
ANALYST COVERAGE11 analysts
HOLD
+19.1%upside to target
L $102.00
Med $105.00consensus
H $113.00
Buy
545%
Hold
655%
5 Buy (45%)6 Hold (55%)0 Sell (0%)
Full report →
Stock Health
Composite Score
1 of 4 signals bullish
5/10
Technicals
RSI RangeRSI 44 — Bearish momentum
Volume
Volume FlowNeutral
~
Fundamentals
Last EarningsBeat estimates
Analyst ConsensusHold
~

1 signal unavailable — limited data for this stock

Upcoming Events
EEarnings Report · After CloseMay 7, 2026
Tomorrow
DEx-Dividend DateAug 4, 2026
In 90 days
PDividend PaymentAug 6, 2026
In 92 days
Technicals
Technical SetupBEARISH
Technicals →

Trend

DowntrendDeath Cross · 50D trails 200D by 1.0%

-11.8% vs SMA 50 · -12.7% vs SMA 200

Momentum

RSI44.4
Momentum fading
MACD+2.48
Above zero — bullish momentum · expanding
Market Position
Price Levels
52W High
$110.1+24.9%
EMA 50
$100.9+14.5%
EMA 200
$90.72+2.9%
Current
$88.13
52W Low
$84.99-3.6%
52-Week RangeNear 52-week low
$84.9913th %ile$110.1
Squeeze SetupVolume-based
No Clear Setup

Volume distribution is neutral or leaning toward distribution. No compelling squeeze setup based on current money flow data.

20-Day Money Flow
Acc days:3
Dist days:5
Edge:+2 dist
Volume Context
Avg Vol (50D)1.2M
Recent Vol (5D)
1.5M+26%

Based on volume distribution analysis. Direct short interest data (short float %, days to cover) is not available in current data sources.

Earnings & Analysts

ANALYST ESTIMATES

Consensus of 12 analysts
Analyst revisions:EPS↓ Revised DownRevenue↓ Revised Down

Analyst consensus estimates · Actuals replace estimates as reported

YearRevenue Est.Rev GthEPS Est.EPS GthRangeAnalysts
FY2024
$5.2B
$5.2B$5.2B
$3.48
±0%
High9
FY2025
$5.5B
$5.5B$5.5B
+6.2%$3.84+10.4%
±0%
High11
FY2026(current)
$5.9B
$5.8B$5.9B
+6.4%$4.24+10.4%
±1%
High12
Range confidence:Tight (high)ModerateWide (low)
🔥Beat 8 consecutive quarters
Earnings HistoryVLTO
Last 8Q
+5.9%avg beat
Beat 8 of 8 quarters Estimates rising
+6%
Q3'24
+5%
Q4'24
+6%
Q1'25
+10%
Q2'25
+5%
Q3'25
+5%
Q4'25
+6%
Q1'26
+5%
Q2'26
Beat
Miss
Estimate
Deeper color = bigger beat/miss
Analyst Activity
All ratings →
No recent activity
JefferiesHold
Dec 10
DOWNGRADE
Wolfe ResearchOutperform
Jul 30
UPGRADE
Vertical ResearchBuy
Oct 16
UPGRADE
Insider Activity
SEC Filings →
0 Buys/6 SellsNet Selling
NET SELLERS$0 bought · $26K sold · 30d window
Skeete Bernard MChief Accounti…
$26K
May 1
SELL
Kapity MelissaSVP, Water Qu…
$686K
Feb 27
SELL
Bystrom MattiasSVP, PQI
$102K
Dec 1
SELL
Honeycutt JenniferDir
$1.1M
Aug 29
SELL
Trivedi SurekhaSVP, Strategy …
$85K
Jun 2
SELL
Beneteau LesleySVP, CHRO
$46K
May 15
SELL
Financials
Dividends0.54% yield
+23.4% avg annual growth
Annual Yield0.54%
Quarterly Div.$0.1300
Est. Annual / Share$0.52
FrequencyQuarterly
Q2'24
Q3'24
Q4'24
Q1'25
Q2'25
Q3'25
Q4'25
Q1'26

Dividend per payment — last 8 periods

INSTITUTIONAL OWNERSHIP

1
Pictet Asset Management Holding SA
3.2M
2
Nuveen, LLC
2.0M
3
SG Americas Securities, LLC
1.7M
4
Robeco Institutional Asset Management B.V.
1.5M
5
PRINCIPAL FINANCIAL GROUP INC
1.1M
6
Swedbank AB
975K
7
HSBC HOLDINGS PLC
888K
8
TEACHER RETIREMENT SYSTEM OF TEXAS
633K
News & Activity

VLTO News

20 articles · 4h ago

About

No description available.

Ryan A. TaylorVice President of Investor Relations
Vaneet MalhotraSenior Vice President of Corporate Development
Surekha TrivediSenior Vice President of Strategy & Sustainability
PeersIndustrials(7 companies)
Screen sector →
SymbolPriceDay %Mkt CapP/ERev GrwMarginELO
VLTO
$88.13-0.12%$21.6B22.5+597.0%1708.2%1482
$904.59-1.67%$420.9B44.5+429.0%1312.8%1523
$286.68+2.20%$299.5B34.4+1848.2%1898.2%1489
$172.87-0.02%$232.8B32.1+974.1%759.8%1487
$224.38+1.39%$176.9B81.0+3449.4%249.7%1503
$410.86-2.74%$159.4B40.0+1033.0%1489.7%1507
$264.01+0.23%$156.7B21.7+107.2%2912.3%1506
Sector avg-0.11%39.4+1205.4%1475.8%1500